Axsome Therapeutics (AXSM) Tops Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts AXSM Hot Sheet
Join SI Premium – FREE
Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.22), $0.08 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $121.46 million versus the consensus estimate of $121.58 million.
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Starts Holley (HLLY) at Buy
- ExxonMobil outlines key factors for Q2 2026 earnings outlook
- U.S. military launching series of strikes against Iran
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
